renal cell carcinoma icd 10

I-Renal cell carcinoma (RCC), uhlobo oluqhelekileyo lomhlaza wezintso, luhlelwa kusetyenziswa i-International Classification of Diseases, Ukuhlaziywa kweShumi (ICD-10) ngenjongo yokuxilonga kunye nezibalo. Ukuqonda ngokuthe ngqo ICD-10 iikhowudi ezinxulumene nayo renal cell carcinoma ibalulekile ekugcineni irekhodi echanekileyo, ukuhlawula, kunye nophando. Eli nqaku linika isishwankathelo esineenkcukacha ezifanelekileyo ICD-10 codes, staging, ukuxilongwa, kunye nonyango ukhetho lwe renal cell carcinoma.Ukuqonda iiKhowudi ze-ICD-10 zeRenal Cell CarcinomaUhlelo lweZifo lwamazwe ngamazwe, uHlaziyo lweShumi (ICD-10) yinkqubo eyaziwa kwihlabathi jikelele yokuhlela izifo kunye neemeko zempilo. Kuba renal cell carcinoma, iikhowudi ezithile zisetyenziselwa ukuchonga uhlobo, indawo, kunye nenqanaba lomhlaza. Ukubhalwa kwekhowudi ngokuchanekileyo kubalulekile ekuqokeleleni idatha echanekileyo, ukunika ingxelo kunye nembuyiselo. Ezi khowudi zingezantsi zingasetyenziswa ngoogqirha kumaziko afana ne IZiko loPhando ngoMhlaza laseShandong Baofa.IiKhowudi zoBunyanzeliso eziPhambiliEyokuqala ICD-10 ikhowudi ye-neoplasms eyingozi yezintso yi-C64. Le khowudi iquka amacandelwana amaninzi achaza ngakumbi indawo kunye necala (intso yasekhohlo okanye ekunene): C64.1 - I-neoplasm embi yezintso zasekunene, ngaphandle kwe-pelvis ye-renal C64.2 - I-neoplasm enobungozi kwizintso zasekhohlo, ngaphandle kwe-pelvis ye-renal C64.9 -I-neoplasm enobungozi kwizintso ezingachazwanga, ngaphandle kwe-renal pelvisSecondary Malignancy CodesIf renal cell carcinoma i-metastasized (isasazeke) kwezinye iindawo zomzimba, iikhowudi zesibini ezinobungozi zisetyenziselwa ukongeza kwikhowudi yokuqala. Imizekelo ibandakanya: C79.0 - I-neoplasm enobungozi yesibini yezintso kunye ne-renal pelvis (Oku akuyi kusetyenziswa njengekhowudi yokuqala renal cell carcinoma.) C79.51 - I-neoplasm enobungozi yesibini yethambo C78.0 - I-neoplasm enobungozi yesibini yemiphunga C77.3 -I-neoplasm enobungozi yesibini ye-axilla kunye ne-lymph node yelungu eliphezulu Uxilongo kunye neStaging of Renal Cell Carcinoma Ukuxilongwa ngokufanelekileyo kunye nesiteji kubalulekile ekumiseni isicwangciso sonyango esifanelekileyo renal cell carcinoma. Ezi ndlela zilandelayo zidla ngokusetyenziswa: Iinkqubo zokuxilonga Uvavanyo lomfanekiso: I-CT scans, i-MRIs, kunye ne-ultrasounds zisetyenziselwa ukujonga izintso kunye nokuchonga amathumba anokubakho. I-Biopsy: Isampula yethishu ithathwa kubunzima bezintso kwaye ihlolwe phantsi kwe-microscope ukuqinisekisa ubukho beeseli zomhlaza. Uvavanyo lomchamo: Inokubona igazi okanye ezinye iziphene ezibonisa iingxaki zezintso. Uvavanyo lwegazi: Vavanya ukusebenza kwezintso kunye nempilo iyonke.I-TNM Staging SystemInkqubo yokubonisa ye-TNM isetyenziswa ngokubanzi ukuhlela ubungakanani renal cell carcinoma: T (Ithumba): Ichaza ubungakanani kunye nobungakanani bethumba lokuqala. N (iiNodi): Ibonisa ukuba umhlaza unwenwele na kwii-lymph nodes ezikufutshane. M (iMetastasis): Imisela ukuba ngaba umhlaza uye we-metastasized kwiindawo ezikude.Izigaba ze-TNM zivela kwiNqanaba I (i-tumor yendawo) ukuya kwiSigaba IV (isifo se-metastatic). Inqanaba yinto ephambili ekumiseleni i-prognosis kunye nokhetho lonyango.Iinketho zonyango lweRenal Cell CarcinomaTreatment for renal cell carcinoma kuxhomekeke kwizinto eziliqela, kuquka inqanaba lomhlaza, impilo yomguli, nezinto azikhethayo. Iindlela zonyango eziqhelekileyo zibandakanya: Utyando Ukususwa kwethumba kuhlala lolona nyango luphambili lwendawo renal cell carcinoma. Ukhetho lotyando lubandakanya: I-Nephrectomy engaphelelanga: Ukususwa kwethumba kunye nomda omncinci wezicubu eziphilileyo. I-Radical Nephrectomy: Ukususwa kwezintso zonke, izicubu ezijikelezileyo, kunye ne-lymph nodes.I-Targeted TherapyTargeted therapy amayeza athintela iimolekyuli ezithile ezibandakanyekayo ekukhuleni kweeseli zomhlaza kunye nokuphila. La machiza anokusebenza kwizinga eliphezulu renal cell carcinoma kwaye zihlala zisetyenziswa xa utyando alukho ukhetho okanye emva kotyando ukukhusela ukuphindaphinda. Imizekelo ibandakanya: Sunitinib (Sutent) Pazopanib (Votrient) Axitinib (Inlyta) Cabozantinib (Cabometyx)ImmunotherapyImmunotherapy Amachiza omeleza amajoni omzimba ukulwa iiseli zomhlaza. La machiza abonise iziphumo ezithembisayo kunyango oluphambili renal cell carcinoma. Imizekelo ibandakanya: I-Nivolumab (Opdivo) Pembrolizumab (Keytruda) Ipilimumab (Yervoy) Unyango lweRadiation TherapyUnyango lonyango lusebenzisa imitha yamandla aphezulu ukubulala iiseli zomhlaza. Ngamanye amaxesha isetyenziselwa ukunyanga renal cell carcinoma eziye zasasazeka kwezinye iindawo zomzimba okanye ukuthomalalisa iimpawu ezinjengeentlungu.Ukuhlolwa okuSebenzayoKumathumba amancinci, akhula kancinane, ucupho olusebenzayo (ukubeka iliso olusondeleyo) lunokuba lukhetho. Oku kubandakanya iimvavanyo zemifanekiso rhoqo ukujonga ukukhula kwethumba, kunye nonyango luqaliswe ukuba ithumba liqala ukukhula okanye libangele iimpawu.I-Prognosis kunye neRates SurvivalThe prognosis for renal cell carcinoma iyahluka ngokuxhomekeke kwinqanaba lomhlaza kunye nezinye izinto. Inqanaba lokuqala renal cell carcinoma inezinga eliphezulu lokusinda emva kokususwa ngotyando. Nangona kunjalo, phambili renal cell carcinoma kulucelomngeni ukunyanga, kwaye izinga lokusinda lisezantsi. Ukuqhubela phambili kunyango olujoliswe kuyo kunye nonyango lwe-immunotherapy luye lwaphucula ukuxilongwa kwezigulane ezinesifo esiphezulu.Itheyibhile elandelayo ibonisa amazinga okusinda kwiminyaka emi-5 kwizigaba ezahlukeneyo. renal cell carcinoma ngokusekelwe kwiinkcukacha ezivela kwi-American Cancer Society: Inqanaba le-5-Year Survival Rate Stage I 93% Stage II 81% Stage III 74% Stage IV 13% *Amazinga okusinda ayaqikelelwa kwaye anokwahluka ngokusekelwe kwiimeko zomntu ngamnye.IsipheloUkuqonda i ICD-10 inkqubo yekhowudi ye renal cell carcinoma, kunye nokuxilongwa kwayo, isiteji, kunye nokhetho lonyango, lubalulekile kubasebenzi bezempilo kunye nezigulana. Ukufunyanwa kwangoko kunye nonyango olufanelekileyo kunokuphucula kakhulu iziphumo. Ukuze ufumane inkcazelo engakumbi ngomhlaza uphando kunye nonyango, nceda undwendwele Shandong Baofa Cancer Research Institute malunga nathi page.I-Disclaimer: Le ngcaciso yenzelwe iinjongo zemfundo kuphela kwaye akufanele ithathwe njengengcebiso yezonyango. Qhagamshelana nengcali yezempilo eqeqeshiweyo ngayo nayiphi na inkxalabo yezempilo okanye ngaphambi kokuba wenze naziphi na izigqibo ezinxulumene nempilo okanye unyango lwakho.Imithombo: Umbutho womhlaza waseMelika: https://www.cancer.org/ Iziko leSizwe loMhlaza: https://www.cancer.gov/